Optimization of GDMT for patients with heart failure and reduced ejection fraction: can physiological and biological barriers explain the gaps in adherence to heart failure guidelines?

Marilyne Jarjour, Anique Ducharme

Open source

DOI
10.7573/dic.2023-5-6
Published
2023-11-16
Container
Drugs in Context
Publisher
BioExcel
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.7573/dic.2023-5-6,
  title = {Optimization of GDMT for patients with heart failure and reduced ejection fraction: can physiological and biological barriers explain the gaps in adherence to heart failure guidelines?},
  author = {Marilyne Jarjour and Anique Ducharme},
  year = {2023},
  journal = {Drugs in Context},
  doi = {10.7573/dic.2023-5-6},
  url = {https://doi.org/10.7573/dic.2023-5-6}
}

RIS

TY  - JOUR
TI  - Optimization of GDMT for patients with heart failure and reduced ejection fraction: can physiological and biological barriers explain the gaps in adherence to heart failure guidelines?
AU  - Marilyne Jarjour
AU  - Anique Ducharme
PY  - 2023
JO  - Drugs in Context
DO  - 10.7573/dic.2023-5-6
UR  - https://doi.org/10.7573/dic.2023-5-6
ER  - 

APA

Jarjour, M., & Ducharme, A. (2023). Optimization of GDMT for patients with heart failure and reduced ejection fraction: can physiological and biological barriers explain the gaps in adherence to heart failure guidelines?. Drugs in Context. https://doi.org/10.7573/dic.2023-5-6

Source records